Literature DB >> 2025591

Temporal and interindividual variation in erythrocyte zinc-protoporphyrin in lead exposed workers.

P Grandjean1, P J Jørgensen, S Viskum.   

Abstract

Nineteen male workers from a factory making lead batteries participated in monthly blood tests to follow the effects of decreasing exposures to lead. The overall average blood lead (B Pb) concentration was 1.95 mumol/l (40 micrograms/100 ml), but a significant decrease was seen over the one year study period. The relation to erythrocyte zinc-protoporphyrin (ZPP) concentration showed considerable scatter and only marginal improvement of the relation was obtained when each ZPP result was compared with the average B Pb concentration during the previous four months. On an individual basis, five men showed a considerable decline in ZPP following decreases in B Pb concentration. In five other subjects with similar decreases in B Pb, no change in ZPP concentration was seen. These two groups were similar with regard to haemoglobin concentration, initial B Pb concentration, and age, but differed in duration of exposure. A longer exposure time and presumably, therefore, larger body burdens of lead seemed to prevent the expected decrease in erythrocyte ZPP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025591      PMCID: PMC1035365          DOI: 10.1136/oem.48.4.254

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  13 in total

1.  Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin.

Authors:  A A Lamola; S Piomelli; M G Poh-Fitzpatrick; T Yamane; L C Harber
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

2.  Standardization of hemoglobinometry. II. The hemiglobincyanide method.

Authors:  E van KAMPEN; W G ZIJLSTRA
Journal:  Clin Chim Acta       Date:  1961-07       Impact factor: 3.786

3.  Biochemical response of male volunteers ingesting inorganic lead for 49 days.

Authors:  A Cools; H J Sallé; M M Verberk; L Zielhuis
Journal:  Int Arch Occup Environ Health       Date:  1976-12-15       Impact factor: 3.015

4.  Effect of lead and genetic factors on heme biosynthesis in the human red cell.

Authors:  S Sassa; S Granick; A Kappas
Journal:  Ann N Y Acad Sci       Date:  1975-04-15       Impact factor: 5.691

5.  Occupational lead exposure in Denmark: screening with the haematofluorometer.

Authors:  P Grandjean
Journal:  Br J Ind Med       Date:  1979-02

6.  Renal function impairment in secondary lead smelter workers: correlations with zinc protoporphyrin and blood lead levels.

Authors:  R Lilis; J Valciukas; A Fischbein; G Andrews; I J Selikoff; W Blumberg
Journal:  J Environ Pathol Toxicol       Date:  1979 Jul-Aug

7.  Psychological dysfunctions in lead-exposed workers. Relation to biological parameters of exposure.

Authors:  P Grandjean; E Arnvig; J Beckmann
Journal:  Scand J Work Environ Health       Date:  1978-12       Impact factor: 5.024

8.  Changes in rat liver microsomal cytochrome P-450 and enzymatic activities after the inhalation of n-hexane, xylene, methyl ethyl ketone and methylchloroform for four weeks.

Authors:  R Toftgård; O G Nilsen; J A Gustafsson
Journal:  Scand J Work Environ Health       Date:  1981-03       Impact factor: 5.024

9.  Erythrocyte-Zn-protoporphyrin as an indicator of lead exposure.

Authors:  P Grandjean; J Lintrup
Journal:  Scand J Clin Lab Invest       Date:  1978-11       Impact factor: 1.713

10.  Zinc protoporphyrin level in blood determined by a portable hematofluorometer: a screening device for lead poisoning.

Authors:  W E Blumberg; J Eisinger; A A Lamola; D M Zuckerman
Journal:  J Lab Clin Med       Date:  1977-04
View more
  1 in total

1.  Lead absorption and renal dysfunction in a South African battery factory.

Authors:  R Ehrlich; T Robins; E Jordaan; S Miller; S Mbuli; P Selby; S Wynchank; A Cantrell; M De Broe; P D'Haese; A Todd; P Landrigan
Journal:  Occup Environ Med       Date:  1998-07       Impact factor: 4.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.